The Case Comprehensive Cancer Center’s (Case CCC) overall goal is to provide equal access to research studies for all patients in the Case CCC catchment area. While the Case CCC leadership recognizes that achieving a clinical trial participant population that mirrors the overall minority patient population may not be feasible for many reasons which are similar to those faced by other institutions, this remains the Case CCC goal. In an effort to minimize the gap between minority and non-minority patient participation in clinical trials, Case CCC has undertaken a variety of activities in areas such as research, education, and outreach. A structured approach was facilitated by the establishment of a Minority Accrual Task Force, now a standing Case CCC Minority Accrual Committee (MAC).
To increase awareness and improve institutions’ ability to engage minority populations in understanding, communicating about and decision making regarding participation in research studies.
- Provide direction for all minority clinical trial awareness and participation-related activities at participating institutions;
- Increase awareness of racial/ethnic issues related to participation in research studies;
- Identify and implement strategies to assist institutions and oncology clinicians and staff to discuss and address issues of clinical trials with minority patients, their families and caregivers;
- Make clinicians and staff aware of existing barriers in minority participation in clinical trials;
- Make clinicians and staff aware of existing resources to overcome barriers;
- Develop new tools and appropriate training in the area of cultural competency;
- Identify and implement best practices in the area of minority participation in clinical trials;
- Bridge minority participation-related activities at individual institutions;
- Provide a forum for members to report their respective activities and experiences, share ideas, and learn from one another; and
- Provide a platform to collaborate among participating institutions on specific tasks.
Organization and Membership
The Minority Accrual Task Force was established in January 2010 with representatives from Case CCC and UH Seidman Cancer Center (SCC). The goal of the Task Force was to identify specific plans to increase Case CCC minority awareness and participation in clinical trials to more closely mirror the UH patient population. In March 2011, the Minority Accrual task Force developed a series of short-term, intermediate, and long-range recommendations to address the need for greater minority awareness and participation in clinical trials. Areas of concentrated focus included: Institution, Physicians, Patients, Training & Education, Marketing & Media, Medical Community, Community Relationships, and Other.
Case CCC MAC was established in June 2012, based on the activities and membership of the Minority Accrual Task Force. At the time of MAC establishment, membership expanded to representatives from the Cleveland Clinic and community. Currently, the Committee also includes representatives from the Case Center for Reducing Health Disparities.
Case CCC MAC meets once a month on the 3rd Wednesday, 11am, UH, Wearn building, room 149; call-in option is available.
MAC Chair: Smitha Krishnamurthi, MD, Medical Director, Case CCC Clinical Research Office
MAC Coordinator: Katarzyna Karelus, MS, MBA (216.844.4176; email@example.com)